Table 3.

MG-ADL subscores for MG symptoms during the follow-up periods.

Items of MG-ADL (n)	Subscores, median (IQR)
	Baseline	1 month	3 months	6 months	12 months
Ptosis (39)	3 (2–3)	2 (1–3)	1 (0–2)	0 (0–2)	0 (0–1)
Diplopia (30)	2 (1–3)	1 (1–2.5)	1 (0–2.5)	1 (0–2)	0 (0–1.5)
Talking (15)	1 (1–2)	1 (1–1)	0 (0–1)	0 (0–1)	0 (0–0.5)
Chewing (20)	1 (1–2)	1 (0–1)	1 (0–1)	0 (0–1)	0 (0–0)
Swallowing (18)	1 (1–2)	1 (0–1.25)	0 (0–1)	0 (0–0)	0 (0–0)
Breathing (8)	1 (1–1.75)	1 (0.25–1)	1 (0–2)	1 (0–1)	0 (0–0.5)
Limbsa (7)	2 (2–4)	2 (1–4)	1.5 (0–2.25)	1.5 (0–2.25)	0 (0–1.25)

^aLimbs included upper and lower limbs.

MG-ADL, myasthenia gravis-specific activities of daily living scale; n, number of patients with the symptom at baseline.